Good Lifestyle

At the beginning of the Pandemic of Covid, doctors and scientists were on hunting to succeedtreatments that could reduce the virus toll. At this point, several promising candidates have emerged, many of whom are already on the market to deal with other diseases. Now another potential treatment of COVID attaches the list in the form of a widely available and thoroughly tested inhaler, traditionally used to treat asthma and chronic obstructive pulmonary disease (COPD). According to a new study of the Nihr Oxford Biomedical Research Center, which has not yet been examined by peers, the drug budesonide was found atReduce the risk of serious illness of 90%. Read more about this innovative treatment for Covid and for the latest vaccine news, discoverDr. Fauci says you will easily get an appointment with the vaccine after this date.

Observing a total of 146 subjects, the researchers gave half of the group a budsonide inhaler for doses twice daily of 800 micrograms and the other half-placebo for a period of 28 days. Those who took the treatment were not only 90%less likely to require urgent careThey would also have benefited from shorter fever duration and fewer long-term symptoms.

"I am encouraged to see the reduction of persistent symptoms at 14 and 28 days after treatment with budesonide"Mona Bafadhel, MD, Professor and Respiratory Consultant also working at Oxford University NHS Foundation Trust Hospitals, shared on theUniversity of Oxford Website. "Persistent symptoms after the initial CVIV-19 disease has emerged as a long-term problem. Any intervention that could solve this problem would be a major step," she added.

The study would have been inspired by the observation that fewChronic asthma patients were admitted to the hospital during the first months of the pandemic. The results can confirm that this trend was due to the use of corticosteroid inhalers preventing more serious respiratory effects. If confirmed, the discovery could save countless lives.

"Immunization programs are really exciting, but we know that they will take time to reach everyone around the world," said Bafadhel. "I'm stirredRelatively safe medicine, widely available and well studied As an inhaled steroid could have an impact on the pressures we live during the pandemic. "

Are you wondering how you can reduce your risk of severe covidation? Continue reading for more ways to maintain the verification virus and more and more of your potential level of risk, checkIf you have this common habit, your Covid symptoms will be worse.

Budesonide is not the only medicine already on the market that can fight Covid. According to a recent Canadian study, which has not yet been examined by peers, aAnti-inflammatory gout drug called Colchicine Could also considerably reduce the hospitalization and death rate of the new coronavirus.

Researchers exhort that beyond these advantages,colchicine is also cheap, administered orally and has little known side effects. In addition, the team indicated that the treatment group presented with fewer cases of pneumonia and demonstrated a reduced need for additional oxygen. And for more medications that can potentially help to help serious cases, discoverThis medicine could reduce your risk of dying from Covid, say experts.

New research also reveal that those who take aDaily dose of aspirin Can feel better covidant results than those who do not.

An October study in the newspaperAnesthesia and Analgesia Examined medical records of more than 400 hospitalized coronavirus patients from March to July. Among these patients, those who tooka low daily dose of aspirin Have been deemed by 43% less likely to be transferred to the Intensive Care Unit (ICU) and 44% less likely to be placed on a fan. Finally, these same patients were also 47% less likely to die of COVID than hospitalized patients who did not take aspirin daily. And to avoid contracting the virus in the first place, discoverWhere you are most likely to catch Covid now, a new study says.

According to an December study that has not yet been examined by peers, aSimple nasal spray Can have a profound effect on the new coronavirus. Through in vitro trials, researchers have found thatXlear sinus care Can help neutralize Covid-19: it was able to significantly reduce the amount of COVID virus active after only 25 minutes.

The ingredients of the sprayer comprise the xylitol-has often used as sweetening as well as grapefruit grape grain extract (Gse) and 0.85% saline solution. "The therapy combined with GSE and Xylitol can prevent the spread of viral respiratory infections not only for SARS-COV-2 but also for future H1N1 viral epidemics or other viral epidemics," wrote the authors of the study. "GSE considerably reduces the viral load while the xylitol prevents the fastening of the virus to the central protein of the cell wall." And for more Covid news sent directly to your inbox,Sign up for our daily newsletter.

Blood clots are a common event with COVID, affecting about one third of the serious patients, according to a meta-analysis of January published in the newspaperMedical assumptions. And that's whyanti coagulants can be the answer. In a study of 202e February 20021 published inThe BMJThe researchers examined data on 4,297 Covid patients from the United States Veterans Department whose average age was 68 years old. They found thatCovidant patients who have received blood diligents Within 24 hours of being admitted to the hospital, it has reduced their deathishes of 34% compared to people who have not received the drug.

Although more research is needed, the authors of the study say that their conclusions "provide strong actual global evidence to guidelines recommending the use of prophylactic anticoagulation such asInitial treatment for patients With the admission to the hospital of Covid-19 on the hospital. "And for more what can reduce your risk of covidation, seeThese 3 vitamins could save you discoveries from the severe Covid study..